VitalPath Appoints New Chief Commercial Officer

VitalPath, specializing in the design and manufacturing of custom, highly complex catheter solutions for medical device OEMs, has named Rich Rivard as Chief Commercial Officer. 

 

Rivard commented, “As we refine our commercial strategy and enhance our customer journey to support our growth, I am confident in our ability to fulfill our mission. We are committed to delivering exceptional, high-quality, complex catheter solutions in partnership with our customers to help dramatically improve quality of life for patients around the world.”

 

Rivard has over 25 years of progressive sales, commercial excellence, and strategic leadership experience at industry-leading organizations spanning $250M – $3B in annual revenue. He has helped create and lead success in building scalable commercial organizations, team development, revenue and pipeline growth, and M&A activities within the MedTech CDMO space. 

 

Before joining VitalPath, Rivard held executive roles at Vantedge Medical, Heraeus Medevio, and Donaldson Company, Inc. His commercial and marketing strategies helped drive significant account and revenue growth at these public, private, and sponsor-owned organizations. 

 

“Rich’s background as a business integration and transformation expert aligns perfectly with our vision. As we embark on this exciting chapter, Rich’s expertise will be instrumental in shaping our future. His arrival underscores VitalPath’s commitment to deliver for our OEM customers as well as the end users and patients who benefit from our products,” said Andrew Holman, CEO.